Blog

A coronary artery calcium (CAC) scan uses low-dose CT to detect and measure calcified plaque in coronary arteries. Calcium deposits indicate atherosclerosis (plaque buildup). The scan produces a CAC score (Agatston score) reflecting the amount of calcium. Higher scores indicate more atherosclerosis and higher cardiovascular risk. Procedure: lie on CT table; brief breath holds; no contrast typically needed; 10-15 minutes; low radiation dose (about 1 mSv — similar to mammogram or one year of natural background). Useful for adults with intermediate cardiovascular risk to refine assessment. Agatston score categories: 0 (no calcified plaque, very low 10-year CV risk, very reassuring), 1-10 (minimal calcification, low risk), 11-100 (mild calcification, intermediate risk), 101-400 (moderate calcification, moderate to high risk), over 400 (severe calcification, high risk). Why adults with diabetes might consider CAC scan: diabetes alone is “risk-enhancing” but CAC provides personalized assessment; CAC 0 in adults with diabetes shows much lower CV risk than diabetes alone would suggest (may modify treatment intensity); CAC over 100 confirms high risk; adults at borderline cardiovascular risk especially; adults uncertain about statin therapy; family history of premature heart disease + diabetes; young adults with diabetes evaluating long-term risk. ACC/AHA 2018 guidelines recommend CAC for selected adults with intermediate CV risk to refine decision on statin therapy. Limitations: doesn’t detect non-calcified (soft) plaque (which can also cause heart attacks), doesn’t assess stenosis severity (calcium present but degree of narrowing unclear without contrast), cost ($100-500 out of pocket, insurance coverage variable), radiation exposure (low but not zero), incidental findings may require further workup, not replacement for clinical judgment, annual CAC not appropriate (scores change slowly; repeat in 5-10 years if needed).

CAC Score Interpretation

CAC in Diabetes Decision-Making

• Diabetes alone is “risk-enhancing factor” per ACC/AHA guidelines.
• CAC 0 in adults with diabetes — much lower CV risk than estimated by diabetes alone.
• May support holding statin therapy in some borderline situations.
• CAC over 100 confirms high CV risk; supports aggressive intervention.
• Helps individualize statin therapy decisions.
• Better than estimated risk for many adults.
• Not appropriate for very low risk (waste) or very high risk (treatment already indicated).
• Best for “intermediate” risk adults seeking clarification.

When CAC Might Be Indicated

• Adults with intermediate cardiovascular risk (5-20% 10-year risk).
• Adults uncertain about statin therapy.
• Family history of premature heart disease.
• Young or middle-aged adults wanting personalized assessment.
• Adults with one risk factor (like diabetes alone) at borderline.
• Decision-aid for cardiovascular preventive therapy.
• Patient preference for objective evidence.
• Not indicated: very low risk, very high risk, established CV disease, recent acute coronary syndrome.

Procedure and Results

• Lie on CT scanner table.
• EKG leads attached (gates to heart rhythm).
• Brief breath holds during scan.
• 10-15 minutes total.
• No IV contrast typically required.
• Low radiation dose (1 mSv — similar to mammogram).
• Results: Agatston score for each coronary artery and total.
• Cardiologist review.
• Discuss results with primary care or cardiologist.
• Score doesn’t change rapidly; repeat in 5-10 years if needed.

Limitations

• Doesn’t detect non-calcified plaque.
• Doesn’t measure stenosis severity.
• Younger adults may have CAC 0 with significant soft plaque.
• Doesn’t replace clinical judgment.
• Cost may not be covered by insurance.
• Radiation exposure (small).
• Incidental findings on chest CT.
• Not appropriate for very low or very high risk adults.
• One snapshot in time.

The Bottom Line

A coronary artery calcium (CAC) scan uses low-dose CT to detect and measure calcified plaque in coronary arteries. Calcium deposits indicate atherosclerosis (plaque buildup). The scan produces a CAC score (Agatston score) reflecting the amount of calcium — higher scores indicate more atherosclerosis and higher cardiovascular risk. Procedure: lie on CT table; brief breath holds; no contrast typically needed; 10-15 minutes; low radiation dose (about 1 mSv — similar to mammogram). Useful for adults with intermediate cardiovascular risk to refine assessment. Agatston score categories: 0 (no calcified plaque, very low 10-year CV risk under 1% per year, very reassuring), 1-10 (minimal, low risk), 11-100 (mild plaque, intermediate risk), 101-400 (moderate plaque, moderate to high risk), over 400 (severe plaque, high risk), over 1000 (extensive, very high). Score 0 in middle age provides strong reassurance about CV risk. High scores indicate need for aggressive cardiovascular risk reduction. Why adults with diabetes might consider CAC scan: diabetes alone is “risk-enhancing factor” per ACC/AHA guidelines but CAC provides personalized assessment; CAC 0 in adults with diabetes shows much lower CV risk than diabetes alone would suggest (may modify treatment intensity); CAC over 100 confirms high risk; helps individualize statin therapy decisions; better than estimated risk for many adults. ACC/AHA 2018 guidelines recommend CAC for selected adults with intermediate CV risk to refine decision on statin therapy. Not appropriate for very low risk (waste) or very high risk (treatment already indicated). Best for intermediate risk adults seeking clarification. When indicated: adults with intermediate cardiovascular risk (5-20% 10-year), uncertain about statin therapy, family history of premature heart disease, young or middle-aged adults wanting personalized assessment, decision-aid for preventive therapy. Limitations: doesn’t detect non-calcified (soft) plaque which can also cause heart attacks, doesn’t assess stenosis severity, cost typically $100-500 out of pocket (insurance variable), radiation exposure (low but not zero), incidental findings may require further workup, not replacement for clinical judgment, younger adults may have CAC 0 with significant soft plaque. Annual CAC not appropriate — scores change slowly; repeat in 5-10 years if needed. For adults with type 2 diabetes at intermediate cardiovascular risk seeking personalized assessment to guide treatment intensity, CAC scan provides valuable additional information beyond standard risk calculators. See our broader diabetes heart attack risk guide for context.

Several tests measure magnesium status: serum magnesium (most common; measures circulating; normal 1.7-2.2 mg/dL; limitation — only 1% of body magnesium in serum, can be normal even with deficiency), RBC magnesium (measures cellular stores; more sensitive; normal 4.2-6.8 mg/dL), urinary magnesium (24-hour collection), magnesium loading test (research). For routine clinical use, serum magnesium is most common but may miss subclinical deficiency. Magnesium deficiency is common in adults with diabetes — 25-50% have low levels. Multiple roles: insulin signaling (magnesium needed for insulin receptor function), glucose metabolism (cofactor in glucose utilization), energy production (ATP synthesis), muscle function (including heart), nerve function, bone health, anti-inflammatory effects, cardiovascular health. Causes of deficiency in diabetes: poor dietary intake, increased urinary loss from glycosuria (when blood sugar high), diuretic use (common in diabetes hypertension), reduced absorption, certain medications (PPIs, omeprazole). Low magnesium associated with worsened insulin sensitivity, higher A1C, more diabetic complications, cardiovascular events, leg cramps, fatigue. Signs of deficiency: muscle cramps and twitches, fatigue and weakness, mental status changes (anxiety, depression), sleep problems, headaches and migraines, heart rhythm changes (palpitations), high blood pressure, low calcium and potassium, restless legs syndrome, worsened glucose control, bone problems. Subclinical deficiency may have no obvious symptoms but contributes to chronic disease risk. Food sources: pumpkin seeds (190 mg per oz), spinach (160 mg per cup cooked), almonds (75 mg per oz), black beans (60 mg per ½ cup), dark chocolate (65 mg per oz 70%+), avocado (60 mg per medium), cashews, salmon, quinoa, whole grains. Daily Value: 400-420 mg men; 310-320 mg women. Supplements: magnesium glycinate (well-absorbed; good for sleep), magnesium citrate (good absorption; can have laxative effect), magnesium malate (energy), magnesium oxide (poorly absorbed; cheap), magnesium chloride. Some research suggests magnesium supplementation modestly improves insulin sensitivity in adults with deficiency.

Magnesium Test Comparison

Magnesium and Diabetes Connection

• Magnesium needed for insulin receptor function.
• Cofactor in over 300 enzymatic reactions.
• Low magnesium associated with insulin resistance.
• Increased urinary magnesium loss with elevated blood sugar (glycosuria).
• Cycle: high blood sugar → magnesium loss → worsened insulin resistance → higher blood sugar.
• 25-50% of adults with diabetes have low magnesium.
• Many medications affecting magnesium (diuretics, PPIs, some antibiotics).
• Some studies show magnesium supplementation modestly improves A1C.
• Magnesium adequacy supports overall metabolic health.

Top Food Sources of Magnesium

Magnesium Supplement Types

The Bottom Line

Several tests measure magnesium status: serum magnesium (most common; measures circulating; normal 1.7-2.2 mg/dL; limitation — only 1% of body magnesium in serum, can be normal even with deficiency), RBC magnesium (measures cellular stores; more sensitive; normal 4.2-6.8 mg/dL), urinary magnesium (24-hour collection), magnesium loading test (research). For routine clinical use, serum magnesium is most common but may miss subclinical deficiency. Magnesium deficiency is common in adults with diabetes — 25-50% have low levels. Multiple roles: insulin signaling (magnesium needed for insulin receptor function), glucose metabolism (cofactor), energy production (ATP synthesis), muscle function (including heart), nerve function, bone health, anti-inflammatory effects, cardiovascular health. Causes of deficiency in diabetes: poor dietary intake, increased urinary loss from glycosuria (when blood sugar high), diuretic use (common in diabetes hypertension), reduced absorption, certain medications (PPIs, omeprazole). Low magnesium associated with worsened insulin sensitivity, higher A1C, more diabetic complications, cardiovascular events, leg cramps, fatigue. Signs of deficiency: muscle cramps and twitches, fatigue and weakness, mental status changes (anxiety, depression), sleep problems, headaches and migraines, heart rhythm changes (palpitations), high blood pressure, low calcium and potassium (magnesium affects these), restless legs syndrome, worsened glucose control, bone problems. Subclinical deficiency may have no obvious symptoms but contributes to chronic disease risk. Food sources: pumpkin seeds (190 mg per oz — highest), spinach (160 mg per cup cooked), Swiss chard (150 mg per cup), almonds and cashews (75 mg per oz), dark chocolate 70%+ (65 mg per oz), avocado (60 mg per medium), black beans (60 mg per ½ cup), quinoa (60 mg per ½ cup cooked), salmon, banana, edamame, whole grains. Daily Value: 400-420 mg men; 310-320 mg women. Many adults fall short. Supplements: magnesium glycinate (high bioavailability; best tolerated; good for sleep/anxiety), magnesium citrate (high; can have laxative effect), magnesium malate (energy), magnesium L-threonate (crosses blood-brain barrier; cognitive), magnesium chloride (moderate), magnesium oxide (poorly absorbed; cheap; laxative effect), magnesium sulfate (Epsom salt — topical baths or laxative). Start with 200-400 mg daily; monitor for GI side effects. Some research suggests magnesium supplementation modestly improves insulin sensitivity in adults with deficiency. For adults with type 2 diabetes, magnesium testing is worth considering in adults with symptoms (muscle cramps, fatigue, leg cramps), poor glucose control despite adherence, multiple medications affecting magnesium, or specific clinical concerns. Routine magnesium testing not universal, but adequate magnesium intake through diet (or supplementation if deficient) supports overall metabolic health. See our broader magnesium and blood sugar guide for context.

The folate test measures the level of folate (vitamin B9) in blood. Two main tests: serum folate (reflects recent dietary intake) and red blood cell (RBC) folate (reflects long-term folate status; more accurate for assessing body stores). Normal ranges: serum folate 3-17 ng/mL; RBC folate 280-790 ng/mL. Folate is essential for DNA synthesis and cell division, red blood cell production, pregnancy (neural tube defect prevention), and homocysteine metabolism. Deficiency causes megaloblastic anemia (large red blood cells), elevated homocysteine, and various symptoms. Sometimes ordered with vitamin B12 because they have overlapping functions and deficiencies present similarly. Why adults with diabetes might need folate testing: adults on metformin (though B12 deficiency more common, folate can also be affected), elevated homocysteine (cardiovascular risk marker), anemia evaluation, adults with malabsorption (celiac, Crohn’s, bariatric surgery), adults on certain medications (methotrexate, phenytoin, sulfasalazine), alcoholism, pregnant women with diabetes (adequate folate critical for fetal development), older adults with poor diet, adults with cognitive concerns. Not routine for diabetes monitoring; tested when clinical indication exists. Folate vs folic acid distinction: folate is natural form found in foods (5-methyltetrahydrofolate primarily); folic acid is synthetic form used in supplements and food fortification (must be converted to active form); 5-MTHF (methylfolate) is active form available as supplement (bypasses conversion). Some adults with MTHFR gene variants convert folic acid less efficiently; may benefit from methylfolate supplementation. Most adults convert folic acid adequately. Foods rich in folate: dark leafy greens (spinach, kale, collard greens, turnip greens, mustard greens), legumes (lentils, chickpeas, black beans, kidney beans, pinto beans), asparagus, broccoli, Brussels sprouts, fortified grains and cereals (U.S. grains fortified with folic acid since 1998), citrus fruits, avocado, beets, eggs.

Normal Ranges

Top Folate Food Sources

Folate Deficiency Symptoms

• Megaloblastic anemia (large red blood cells).
• Fatigue and weakness.
• Pale skin.
• Shortness of breath.
• Cognitive issues — memory, concentration.
• Depression.
• Tongue inflammation (glossitis).
• Mouth sores.
• Headaches.
• Pregnancy concerns: neural tube defects in fetus.
• Elevated homocysteine.

Folate and Diabetes

• Metformin can affect folate (less common than B12).
• Homocysteine connection — folate deficiency raises homocysteine.
• Elevated homocysteine — cardiovascular risk marker.
• Diabetes increases cardiovascular risk independently.
• Pregnant women with diabetes — adequate folate critical.
• Some adults with diabetes have suboptimal folate intake.
• Folate adequacy supports red blood cell production.
• Some research suggests folate supplementation may modestly improve cardiovascular markers.
• Not a primary diabetes monitoring test.

Folate Supplementation

• Daily Value: 400 mcg for adults; 600 mcg for pregnant women.
• Most adults get adequate folate from food (especially fortified grains).
• Supplement forms: folic acid (synthetic), folate (natural), 5-MTHF (methylfolate — active).
• Adults with MTHFR mutations may benefit from methylfolate.
• Don’t take high-dose folic acid (over 1000 mcg) without medical supervision — can mask B12 deficiency.
• Vegetarian and vegan diets typically rich in folate from legumes and greens.
• Often combined with B12 in B-complex supplements.

The Bottom Line

The folate test measures the level of folate (vitamin B9) in blood. Two main tests: serum folate (reflects recent dietary intake) and red blood cell (RBC) folate (reflects long-term folate status; more accurate for assessing body stores). Normal ranges: serum folate 3-17 ng/mL; RBC folate 280-790 ng/mL. Folate is essential for DNA synthesis and cell division, red blood cell production, pregnancy (neural tube defect prevention), and homocysteine metabolism. Deficiency causes megaloblastic anemia (large red blood cells), elevated homocysteine, and various symptoms. Sometimes ordered with vitamin B12 because they have overlapping functions. Why adults with diabetes might need folate testing: adults on metformin (though B12 deficiency more common, folate can also be affected), elevated homocysteine (cardiovascular risk marker), anemia evaluation, adults with malabsorption (celiac, Crohn’s, bariatric surgery), adults on certain medications (methotrexate, phenytoin, sulfasalazine), alcoholism, pregnant women with diabetes (adequate folate critical for fetal development to prevent neural tube defects), older adults with poor diet, adults with cognitive concerns. Not routine for diabetes monitoring; tested when clinical indication exists. Symptoms of deficiency: megaloblastic anemia, fatigue, pale skin, shortness of breath, cognitive issues, depression, tongue inflammation, mouth sores. Foods rich in folate: dark leafy greens (spinach 130 mcg per ½ cup, kale, collard greens, turnip greens, mustard greens), legumes (lentils 180 mcg per ½ cup, chickpeas, black beans, kidney beans, pinto beans), asparagus (130 mcg per ½ cup), broccoli, Brussels sprouts, fortified grains and cereals (U.S. grains fortified with folic acid since 1998), citrus fruits, avocado, beets, eggs. Beef liver exceptionally high (215 mcg per 3 oz) but high cholesterol. Folate vs folic acid: folate is natural form found in foods (5-methyltetrahydrofolate); folic acid is synthetic form used in supplements and food fortification; 5-MTHF (methylfolate) is active form available as supplement. Some adults with MTHFR gene variants convert folic acid less efficiently; may benefit from methylfolate. Most adults convert folic acid adequately. Daily Value: 400 mcg for adults; 600 mcg for pregnant women. Most adults get adequate folate from food (especially fortified grains since 1998 mandatory fortification). Don’t take high-dose folic acid (over 1000 mcg) without medical supervision — can mask B12 deficiency. For most adults with type 2 diabetes, folate adequacy is usually maintained through food intake; testing reserved for specific clinical situations (anemia, elevated homocysteine, malabsorption, pregnancy). See our broader diabetes detection guide for context.

Amylase and lipase are enzymes produced by the pancreas; blood tests measure levels. Amylase digests carbohydrates and is produced by pancreas (specifically) and salivary glands. Lipase digests fats and is produced primarily by pancreas. Both enzymes leak into bloodstream when pancreas is damaged or inflamed. Elevated levels (typically 3x upper limit of normal) suggest pancreatitis. Normal ranges: amylase 25-125 U/L; lipase 0-160 U/L (varies by lab). Lipase is more specific for pancreatic problems than amylase. Tests typically ordered together for pancreatitis suspicion. Why important in diabetes: GLP-1 agonist medications (semaglutide/Ozempic, liraglutide/Victoza, tirzepatide/Mounjaro, dulaglutide/Trulicity) have rare association with pancreatitis; SGLT2 inhibitors also have rare pancreatitis association; type 3c diabetes (pancreatogenic) caused by pancreatic damage; adults with diabetes have higher pancreatitis rates (~50% higher than non-diabetic); recurrent or chronic pancreatitis can lead to diabetes; pancreatic cancer rare but elevated risk in diabetes. Tests not routine but ordered when symptoms suggest pancreatitis — typically severe abdominal pain (often radiating to back), nausea/vomiting, fever. Pancreatitis types: acute (sudden onset, severe abdominal pain, can be life-threatening, recovery possible) and chronic (long-term inflammation, permanent damage, can cause diabetes). Causes: gallstones, alcohol abuse, certain medications, high triglycerides, autoimmune conditions, trauma. When to test: severe upper abdominal pain (especially radiating to back), nausea and vomiting, fever and tachycardia, abdominal tenderness, adults on GLP-1 agonists with abdominal symptoms, adults on SGLT2 inhibitors with abdominal symptoms, high triglycerides over 500, new diabetes with severe abdominal symptoms. Lipase elevation typically lasts longer than amylase (lipase up to 2 weeks; amylase up to 5 days).

Normal Reference Ranges

Pancreatitis suspected when lipase or amylase elevated 3x or more above upper limit. Lipase more specific.

Diabetes Medications and Pancreatitis

• GLP-1 agonists: rare pancreatitis association reported.
• Examples: semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide (Byetta, Bydureon).
• Recent meta-analyses suggest small but real increased pancreatitis risk.
• Discontinue if pancreatitis suspected.
• SGLT2 inhibitors: rare pancreatitis association.
• Examples: empagliflozin (Jardiance), dapagliflozin (Farxiga), canagliflozin (Invokana).
• Risk is small; clinical decision balancing benefits.
• DPP-4 inhibitors: similar mechanism to GLP-1s; some pancreatitis concern.
• Examples: sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta).

Symptoms of Pancreatitis

• Severe upper abdominal pain — sudden onset.
• Pain often radiates to back.
• Worse with eating.
• Nausea and vomiting.
• Fever.
• Tachycardia (fast heart rate).
• Abdominal tenderness on exam.
• Sometimes yellow skin (jaundice if blocking bile duct).
• Indigestion or steatorrhea (fatty stools) — chronic pancreatitis.
• Weight loss (chronic pancreatitis).
• Severe cases — shock, organ failure.

When to Test

• Severe abdominal pain especially radiating to back.
• Adults on GLP-1 agonist with abdominal symptoms.
• Adults on SGLT2 inhibitor with abdominal symptoms.
• Adults with gallstone disease and abdominal pain.
• Triglycerides over 500 with abdominal symptoms.
• Alcohol-related abdominal pain.
• Suspected pancreatic cancer.
• Recurrent abdominal symptoms.
• Steatorrhea evaluation.
• Severe weight loss with new diabetes.

Pancreatitis Causes

• Gallstones (about 40% of cases).
• Alcohol abuse (about 30% of cases).
• Hypertriglyceridemia (over 1000 mg/dL).
• Medications — including some diabetes drugs.
• Autoimmune pancreatitis.
• Hypercalcemia.
• Trauma.
• ERCP procedure.
• Infection.
• Pancreas divisum (anatomic variation).
• Idiopathic (no clear cause).

The Bottom Line

Amylase and lipase are enzymes produced by the pancreas; blood tests measure levels. Amylase digests carbohydrates and is produced by pancreas (specifically) and salivary glands. Lipase digests fats and is produced primarily by pancreas. Both enzymes leak into bloodstream when pancreas is damaged or inflamed. Elevated levels (typically 3x upper limit of normal) suggest pancreatitis. Normal ranges: amylase 25-125 U/L; lipase 0-160 U/L (varies by lab). Lipase is more specific for pancreatic problems than amylase — salivary glands also produce amylase. Tests typically ordered together for pancreatitis suspicion. Why important in diabetes: GLP-1 agonist medications (semaglutide/Ozempic, liraglutide/Victoza, tirzepatide/Mounjaro, dulaglutide/Trulicity, exenatide) have rare association with pancreatitis; SGLT2 inhibitors (empagliflozin/Jardiance, dapagliflozin/Farxiga, canagliflozin/Invokana) also have rare pancreatitis association; DPP-4 inhibitors (sitagliptin/Januvia) similar concern; type 3c diabetes (pancreatogenic) caused by pancreatic damage; adults with diabetes have higher pancreatitis rates (~50% higher than non-diabetic); recurrent or chronic pancreatitis can lead to diabetes; pancreatic cancer rare but elevated risk in diabetes. Tests not routine but ordered when symptoms suggest pancreatitis — typically severe upper abdominal pain (often radiating to back), nausea/vomiting, fever, tachycardia. Symptoms: severe upper abdominal pain (sudden onset), pain radiating to back, worse with eating, nausea and vomiting, fever, abdominal tenderness, sometimes jaundice (bile duct blocked), indigestion or steatorrhea (chronic), weight loss (chronic). Severe cases — shock, organ failure. Pancreatitis types: acute (sudden onset, severe, can be life-threatening, recovery possible) and chronic (long-term inflammation, permanent damage, can cause diabetes — type 3c). Causes: gallstones (~40% of cases), alcohol abuse (~30%), hypertriglyceridemia (over 1000 mg/dL), medications, autoimmune, hypercalcemia, trauma, ERCP procedure, infection, pancreas divisum, idiopathic. When to test: severe abdominal pain especially radiating to back, adults on GLP-1 agonists or SGLT2 inhibitors with abdominal symptoms, gallstone disease with pain, triglycerides over 500 with abdominal symptoms, suspected pancreatic cancer, recurrent abdominal symptoms, severe weight loss with new diabetes. Lipase elevation typically lasts longer than amylase (lipase up to 2 weeks; amylase up to 5 days). Cost: $30-100 each. Suspected pancreatitis requires immediate medical evaluation — often ER or hospital admission. Adults on GLP-1 agonists or SGLT2 inhibitors with severe abdominal symptoms should discontinue medication and seek evaluation. See our broader GLP-1 medications guide for context.

The ankle-brachial index (ABI) is a simple, painless test comparing blood pressure at the ankle to blood pressure at the arm. The ratio indicates whether blood is flowing properly through the arteries of the legs. If leg pressure is significantly lower than arm pressure, blockages or narrowing in the arteries (peripheral artery disease — PAD) are suspected. Procedure: lie on table; blood pressure cuffs placed on arms and ankles; Doppler ultrasound used to detect pulses; takes 15-20 minutes; results immediate. Adults with diabetes have 2-4x higher PAD risk than non-diabetic adults — ABI testing is important. ABI values: normal 0.9-1.3, borderline 0.91-0.99, mild PAD 0.7-0.9, moderate PAD 0.4-0.7, severe PAD under 0.4, non-compressible over 1.3 (calcified arteries; common in diabetes; ABI may not be accurate — alternative testing needed). For adults with non-compressible findings, toe-brachial index (TBI) more accurate. Why PAD important in diabetes: 2-4x higher risk, increases foot ulcer and amputation risk, marker for systemic atherosclerosis, often asymptomatic (peripheral neuropathy can mask claudication), increases cardiovascular mortality, treatable if detected, diabetes accelerates progression, combined with neuropathy increases foot complications. Detection enables intervention: cardiovascular risk reduction (statins, ACE inhibitors, antiplatelet therapy), smoking cessation, exercise therapy, occasionally revascularization. ABI is standard initial screening test. ADA recommendations: at diabetes diagnosis (baseline), every 5 years thereafter for adults without PAD, annually for adults over 50, annually with risk factors (smoking, hypertension, dyslipidemia, family history), when symptoms develop. Annual diabetic foot exam should include ABI assessment in adults over 50. Cost: $50-200 typically; covered by insurance with medical necessity.

ABI Interpretation

PAD Symptoms in Diabetes

• Claudication: leg pain with walking; relieved by rest. CLASSIC but often masked in diabetes due to neuropathy.
• Foot pain at rest: especially at night.
• Non-healing foot wounds: due to poor blood flow.
• Cold feet compared to warm hands.
• Pale or bluish skin color in legs.
• Hair loss on legs/feet.
• Shiny skin.
• Diminished pulses in feet.
• Erectile dysfunction — related to systemic vascular disease.
• Asymptomatic: many adults with diabetes have PAD without typical symptoms.

PAD Treatment Approaches

• Risk factor management: statins, ACE inhibitors, antiplatelet therapy (aspirin, clopidogrel), glucose control.
• Smoking cessation: critical — major modifiable risk factor.
• Exercise therapy: supervised walking program; improves claudication.
• Cilostazol: medication for claudication; improves walking distance.
• Pentoxifylline: alternative for claudication.
• Revascularization: angioplasty, stenting, bypass for severe disease or critical limb ischemia.
• Wound care: for foot complications.
• Aggressive cardiovascular risk reduction: PAD = high CV risk.
• SGLT2 inhibitors: cardiovascular benefits in diabetes.

When to Test ABI

• At diabetes diagnosis — baseline.
• Every 5 years for adults without PAD.
• Annually for adults over 50 with diabetes.
• Annually with risk factors.
• New leg pain or claudication.
• Non-healing foot wounds.
• Cold feet.
• Foot color changes.
• Diminished pulses on physical exam.
• Adults with peripheral neuropathy.
• Pre-operative for high-risk procedures.
• Cardiovascular events.

The Bottom Line

The ankle-brachial index (ABI) is a simple, painless test comparing blood pressure at the ankle to blood pressure at the arm. The ratio indicates whether blood is flowing properly through the arteries of the legs. If leg pressure is significantly lower than arm pressure, blockages or narrowing in the arteries (peripheral artery disease — PAD) are suspected. Procedure: lie on table; blood pressure cuffs placed on arms and ankles; Doppler ultrasound used to detect pulses; takes 15-20 minutes; results immediate. Adults with diabetes have 2-4x higher PAD risk than non-diabetic adults — ABI testing is important. ABI values: normal 0.9-1.3, borderline 0.91-0.99, mild PAD 0.7-0.9, moderate PAD 0.4-0.7, severe PAD under 0.4, non-compressible over 1.3 (calcified arteries common in diabetes due to medial calcification; ABI may not be accurate — alternative testing needed). For non-compressible findings, toe-brachial index (TBI) more accurate. Why PAD important in diabetes: 2-4x higher risk, increases foot ulcer and amputation risk substantially, marker for systemic atherosclerosis (also affects heart, brain), often asymptomatic (peripheral neuropathy can mask claudication leg pain with exercise), increases cardiovascular mortality, treatable if detected, diabetes accelerates progression. PAD Symptoms (often masked in diabetes): claudication (leg pain with walking, relieved by rest), foot pain at rest especially night, non-healing foot wounds, cold feet, pale or bluish skin color, hair loss on legs/feet, shiny skin, diminished pulses, erectile dysfunction. Many adults asymptomatic. Treatment: risk factor management (statins, ACE inhibitors, antiplatelet therapy — aspirin or clopidogrel, glucose control), smoking cessation (critical — major modifiable risk factor), exercise therapy (supervised walking improves claudication), cilostazol or pentoxifylline for claudication, revascularization (angioplasty, stenting, bypass) for severe disease or critical limb ischemia, wound care for foot complications, aggressive cardiovascular risk reduction (PAD = high CV risk), SGLT2 inhibitors (cardiovascular benefits in diabetes). ABI is standard initial screening test. ADA recommendations: at diabetes diagnosis (baseline), every 5 years thereafter for adults without PAD, annually for adults over 50, annually with risk factors (smoking, hypertension, dyslipidemia, family history), when symptoms develop. Annual diabetic foot exam should include ABI assessment in adults over 50. Cost: $50-200 typically; covered by insurance with medical necessity. For adults with type 2 diabetes, ABI screening is essential preventive care — detects treatable vascular disease before symptoms develop. See our broader peripheral artery disease and diabetes guide for context.

Stress tests evaluate how the heart responds to physical exertion or pharmacological stress (medications mimicking exercise). The body’s increased demand for oxygen during stress reveals coronary artery problems that may not appear at rest. Types: exercise EKG/treadmill test (most common), stress echocardiogram (adds ultrasound), nuclear stress test (radioactive tracer shows blood flow), pharmacological stress (for adults who can’t walk), cardiac MRI stress (newer). Why adults with diabetes might need stress test: cardiovascular disease risk 2-4x higher, silent ischemia (autonomic neuropathy can mask symptoms), suspicious symptoms (chest pain, shortness of breath with exertion), abnormal resting EKG, pre-operative evaluation, before starting vigorous exercise program, multiple risk factors. ADA doesn’t recommend routine stress testing for asymptomatic adults with diabetes (high false positive rate). Reserved for symptoms or specific clinical concerns. Procedure: exercise EKG (walk on treadmill, speed and incline gradually increase, 6-15 min, stop when target heart rate or symptoms), stress echocardiogram (same plus ultrasound), nuclear stress test (IV tracer, gamma camera images, 2-4 hours), pharmacological stress (medication-induced for non-walkers). Preparation: avoid food/caffeine 2-4 hours before, bring comfortable walking shoes, continue most medications (some held — check). Results: normal (reassuring), ischemia (heart muscle not getting enough blood — chest pain or EKG changes), abnormal blood pressure response, arrhythmia with exertion, reduced exercise capacity (METs below age-expected), abnormal wall motion (stress echo), reduced blood flow regions (nuclear). Follow-up depends on findings: lifestyle changes, additional testing (cardiac catheterization), medication changes, cardiology referral, intervention. Limitations: false positives common in diabetes; require clinical context.

Stress Test Types

Indications for Stress Test in Diabetes

• Chest pain (typical or atypical).
• Shortness of breath with exertion.
• Unexplained dyspnea.
• Abnormal resting EKG.
• Pre-operative evaluation (high-risk surgery).
• Pre-exercise assessment (for previously sedentary adults starting vigorous exercise).
• Multiple cardiovascular risk factors.
• Family history of premature CAD.
• Follow-up after heart attack or revascularization.
• Suspicion of silent ischemia in long-standing diabetes.
• Hospital admission evaluation.
• Symptoms after starting medications affecting heart rate.

Diabetes-Specific Considerations

• Autonomic neuropathy can mask chest pain (silent ischemia).
• False positive rate higher in adults with diabetes.
• Risk-benefit assessment important.
• Hypoglycemia risk during exercise — check blood sugar pre-test.
• Insulin or sulfonylurea adjustments needed sometimes.
• Some diabetes medications affect resting EKG.
• Diabetic cardiomyopathy may be detected.
• Left ventricular hypertrophy from hypertension visible.
• Adults with peripheral neuropathy may have difficulty with treadmill.
• Pre-test blood sugar should be 80-200 mg/dL.

What to Expect

• Pre-test: avoid food/caffeine 2-4 hours; bring walking shoes; continue most medications.
• EKG electrodes attached.
• Treadmill or pharmacological agent.
• Heart rate increases to target (about 85% of maximum predicted).
• Test ends when target reached, symptoms develop, or limit reached.
• Brief monitoring after exercise.
• 30-60 minutes total visit (longer for nuclear).
• Results usually same day or within 24-48 hours.
• Cardiologist review.

The Bottom Line

Stress tests evaluate how the heart responds to physical exertion or pharmacological stress. The body’s increased demand for oxygen during stress reveals coronary artery problems that may not appear at rest. Types: exercise EKG/treadmill test (most common, simplest), stress echocardiogram (adds ultrasound for better accuracy), nuclear stress test (radioactive tracer shows myocardial blood flow), pharmacological stress (dobutamine, adenosine, regadenoson — for adults who can’t walk), cardiac MRI stress (newer, expensive), CT coronary angiography (alternative non-invasive). Why adults with diabetes might need stress test: cardiovascular disease risk 2-4x higher, silent ischemia (autonomic neuropathy can mask symptoms), suspicious symptoms (chest pain, shortness of breath with exertion), abnormal resting EKG, pre-operative evaluation, before starting vigorous exercise program, multiple risk factors, follow-up after heart attack. ADA doesn’t recommend routine stress testing for asymptomatic adults with diabetes (high false positive rate). Reserved for symptoms or specific clinical concerns. Procedure: exercise EKG (walk on treadmill, speed and incline gradually increase, 6-15 min, stop when target heart rate or symptoms), stress echocardiogram (same plus ultrasound before and after), nuclear stress test (IV tracer, gamma camera images, 2-4 hours), pharmacological stress (medication-induced for non-walkers). Preparation: avoid food/caffeine 2-4 hours before, bring comfortable walking shoes, continue most medications (some held — check with prescriber), inform of all medications. Diabetes-specific considerations: autonomic neuropathy can mask chest pain (silent ischemia), false positive rate higher in diabetes, hypoglycemia risk during exercise (check blood sugar pre-test 80-200 mg/dL), insulin or sulfonylurea adjustments sometimes needed, peripheral neuropathy may make treadmill difficult. Results: normal (reassuring), ischemia (heart muscle not getting enough blood — chest pain or EKG changes), abnormal blood pressure response, arrhythmia with exertion, reduced exercise capacity (METs below age-expected), abnormal wall motion (stress echo), reduced blood flow regions (nuclear). Follow-up: lifestyle changes, additional testing (cardiac catheterization), medication changes, cardiology referral, intervention (stent, surgery). Limitations: false positives common in diabetes; require interpretation in clinical context. Cost varies: exercise EKG $200-500, nuclear stress test $1,000-3,000, stress echo $1,000-2,500; covered with medical necessity. For adults with type 2 diabetes, stress testing is valuable when clinical indications exist but not for routine screening of asymptomatic adults. See our broader diabetes heart attack risk guide for context.

An echocardiogram uses ultrasound waves to create images of the heart in motion — reveals heart structure (chambers, walls, valves), function (pumping strength, filling), blood flow, and surrounding tissues. Non-invasive, painless, uses no radiation. Types: transthoracic echocardiogram (TTE — most common, probe on chest), stress echocardiogram (combined with exercise or medication-induced stress), transesophageal echocardiogram (TEE — probe inserted through esophagus for clearer images), Doppler (measures blood flow), 3D echo. For most adults with diabetes, TTE is standard. Procedure: lie on table; ultrasound gel applied; probe moved on chest; 30-60 minutes; immediate or near-immediate results. When adults with diabetes need echocardiogram: symptoms (shortness of breath, leg swelling, fatigue), heart murmur on exam, abnormal EKG findings, suspected heart failure, after heart attack, pre-operative evaluation, monitoring known heart conditions, suspected diabetic cardiomyopathy, pulmonary hypertension assessment. Not routine like EKG. Cost: $1,000-3,000 without insurance; covered with medical necessity. Diabetic cardiomyopathy is heart muscle disease specifically associated with diabetes, independent of coronary artery disease — affects 50-60% of adults with type 2 diabetes (often subclinical). Mechanisms: direct hyperglycemia damage, microvascular disease in heart muscle, lipid abnormalities, insulin resistance effects, inflammation. Manifestations: diastolic dysfunction (heart muscle stiffening — impaired relaxation; commonly impaired in diabetes), left ventricular hypertrophy, eventually systolic dysfunction (reduced pumping), restrictive filling pattern. Risk increases with poor glycemic control and longer diabetes duration. Treatment: tight glucose control, blood pressure management, ACE inhibitors, SGLT2 inhibitors (CV outcomes benefit), beta-blockers, weight loss. Echocardiogram is primary diagnostic tool. What echocardiogram shows: ejection fraction (pumping strength, normal 55-70%), LVH (wall thickness), diastolic function, valve function, wall motion abnormalities (prior heart attack or ischemia), pericardial effusion, right heart function, pulmonary pressures.

Echocardiogram Types

Diabetic Cardiomyopathy

• Heart muscle disease associated with diabetes; independent of coronary artery disease.
• Affects 50-60% of adults with type 2 diabetes (often subclinical).
• Mechanisms: hyperglycemia direct damage, microvascular disease in heart, lipid abnormalities, insulin resistance, inflammation.
• Stages: diastolic dysfunction → systolic dysfunction → heart failure.
• Diastolic dysfunction = heart muscle stiffening (impaired relaxation).
• Often progresses over years with continued hyperglycemia.
• Risk factors: poor glucose control, longer diabetes duration, hypertension, obesity.
• Treatment: glycemic control, blood pressure management, SGLT2 inhibitors (cardiovascular outcomes benefit), ACE inhibitors, beta-blockers.
• SGLT2 inhibitors (empagliflozin, dapagliflozin) particularly beneficial for heart failure in diabetes.

Echocardiogram Findings

• Ejection fraction: pumping strength; normal 55-70%; reduced in heart failure.
• Left ventricular hypertrophy: thickened wall; suggests hypertension or strain.
• Diastolic dysfunction: impaired relaxation; common in diabetes.
• Wall motion abnormalities: areas not contracting; prior heart attack or ischemia.
• Valve function: stenosis (narrowing) or regurgitation (leaking).
• Pericardial effusion: fluid around heart.
• Pulmonary hypertension: elevated right-sided pressures.
• Atrial enlargement: associated with atrial fibrillation.
• Right ventricular function.
• Septal wall thickness: in symmetric hypertrophy.

Indications for Echocardiogram in Diabetes

• Shortness of breath, especially with activity.
• Leg swelling (edema).
• Unexplained fatigue.
• Heart murmur on physical exam.
• Abnormal EKG findings.
• Suspected heart failure.
• After heart attack — assess damage.
• Pre-operative evaluation.
• Monitoring known heart conditions.
• Suspected diabetic cardiomyopathy.
• New atrial fibrillation.
• Stroke evaluation.
• Long-standing poorly controlled diabetes with hypertension.

What to Expect

• Lie on examination table.
• Ultrasound gel applied to chest.
• Probe (transducer) moved across chest.
• Hold breath occasionally for clearer images.
• 30-60 minutes typically.
• Painless except slight pressure from probe.
• Continue medications.
• Results read by cardiologist.
• Stress echo: additional exercise or medication injection.
• TEE: requires sedation; pre-test fasting; throat numbing.

The Bottom Line

An echocardiogram uses ultrasound waves to create images of the heart in motion — reveals heart structure (chambers, walls, valves), function (pumping strength, filling), blood flow, and surrounding tissues. Non-invasive, painless, uses no radiation. Types: transthoracic echocardiogram (TTE — most common, probe on chest), stress echocardiogram (combined with exercise or medication-induced stress), transesophageal echocardiogram (TEE — probe inserted through esophagus for clearer images), Doppler (measures blood flow), 3D echo. For most adults with diabetes, TTE is standard. Procedure: lie on table; ultrasound gel applied; probe moved on chest; 30-60 minutes; results immediate or near-immediate. Echocardiogram is not routine for diabetes monitoring like EKG can be — ordered when clinical indication exists. Indications: symptoms (shortness of breath, leg swelling, fatigue), heart murmur on exam, abnormal EKG findings, suspected heart failure, after heart attack, pre-operative evaluation, monitoring known heart conditions, suspected diabetic cardiomyopathy, new atrial fibrillation. Cost: $1,000-3,000 without insurance; covered with medical necessity. Diabetic cardiomyopathy is heart muscle disease specifically associated with diabetes, independent of coronary artery disease — affects 50-60% of adults with type 2 diabetes (often subclinical). Mechanisms: hyperglycemia direct damage, microvascular disease in heart muscle, lipid abnormalities, insulin resistance, inflammation. Progression: diastolic dysfunction (heart muscle stiffening — impaired relaxation; commonly impaired in diabetes) → systolic dysfunction (reduced pumping) → heart failure. Risk increases with poor glycemic control and longer diabetes duration. Treatment: tight glucose control, blood pressure management, SGLT2 inhibitors (empagliflozin, dapagliflozin — heart failure benefit demonstrated in trials), ACE inhibitors, beta-blockers, weight loss. Echocardiogram is primary diagnostic tool. What echocardiogram shows: ejection fraction (pumping strength, normal 55-70%), left ventricular hypertrophy, diastolic function, valve function, wall motion abnormalities (prior heart attack or ischemia), pericardial effusion, right heart function, pulmonary pressures. Process: lie on table, ultrasound gel applied, probe moved across chest, hold breath occasionally, 30-60 minutes typically, painless. Continue medications. Results read by cardiologist. Stress echo adds exercise or medication; TEE requires sedation and pre-test fasting. For adults with type 2 diabetes, echocardiogram is essential when clinical symptoms suggest heart problems or to evaluate diabetic cardiomyopathy. Combined with EKG and other testing, provides comprehensive cardiac assessment. See our broader diabetes heart attack risk guide for context.

An EKG (electrocardiogram, also called ECG) records the electrical activity of the heart through electrodes placed on chest, arms, and legs. Standard 12-lead EKG produces a graph showing rhythm, rate, electrical conduction, and signs of damage or strain. Procedure: lie still on exam table; electrodes placed (sticky pads); 5-10 minutes; painless; results often immediate. EKGs are essential cardiac screening for adults with diabetes. Why important: adults with diabetes have 2-4x higher cardiovascular disease risk; silent ischemia is common (autonomic neuropathy can mask chest pain symptoms); baseline EKG provides reference for future changes; detects arrhythmias (atrial fibrillation more common in diabetes), prior heart attack (sometimes silent), left ventricular hypertrophy (from hypertension), conduction problems, and pre-surgical screening. ADA recommends EKG at diabetes diagnosis and periodically as clinically indicated. What EKG shows: heart rate (normal 60-100 bpm), rhythm (regular vs irregular), atrial fibrillation (common arrhythmia, increases stroke risk), ischemia (heart muscle not getting enough blood — ST depression, T wave inversion), prior heart attack (Q waves), left ventricular hypertrophy, conduction problems, QT interval (prolonged QT dangerous; some medications affect), premature beats, bundle branch blocks. When to get EKG: at diabetes diagnosis (baseline), periodically as clinically indicated, annually for adults over 40 or with risk factors, symptoms (chest pain, shortness of breath, palpitations, fainting), pre-surgical evaluation, starting medications affecting QT interval, pre-exercise stress testing, suspected arrhythmia, follow-up after heart attack, monitoring CV medication therapy. Most primary care offices have EKG machines. Cost: $30-100 without insurance.

EKG Process

• Lie still on examination table.
• 10 electrodes placed on chest, arms, legs.
• Painless, non-invasive.
• Takes 5-10 minutes.
• Avoid talking and moving during recording.
• Avoid exercise within 30 min of test (changes rhythm).
• Avoid alcohol or caffeine immediately before.
• Continue regular medications.
• Results typically immediate.
• Physician reviews and interprets.

What EKG Detects

• Atrial fibrillation: irregular rapid rhythm; increases stroke risk 5x.
• Ischemia: ST depression, T wave inversion; suggests reduced blood flow.
• Prior heart attack: Q waves; permanent EKG changes.
• Left ventricular hypertrophy: thickened heart muscle; from hypertension.
• Bundle branch block: conduction delay; right or left.
• Heart block: AV node conduction problem; degree varies.
• QT prolongation: dangerous arrhythmia risk; some medications.
• Premature ventricular contractions: extra beats.
• Atrial enlargement: chamber dilation.
• Pericarditis: heart sac inflammation.

Diabetes-Specific Concerns

• Autonomic neuropathy may mask chest pain — silent ischemia possible.
• Atrial fibrillation 30-40% more common.
• Hypertension often accompanies diabetes — LVH risk.
• Cardiac autonomic neuropathy (CAN) — affects heart rate variability and orthostatic blood pressure.
• QT prolongation — some diabetes medications and complications affect.
• Adults with neuropathy have increased sudden death risk.
• Hypoglycemia can cause arrhythmias (especially with CAN).
• EKG screens for these concerning patterns.

When to Test

• Diabetes diagnosis — baseline EKG.
• Adults over 40 — annually or as clinically indicated.
• Hypertension diagnosis.
• Pre-surgical evaluation.
• Cardiovascular symptoms (chest pain, dyspnea, palpitations, syncope).
• Starting QT-prolonging medications.
• Pre-exercise stress testing.
• Suspected arrhythmia.
• Follow-up after cardiovascular event.
• Pre-conception planning (for women with diabetes considering pregnancy).

What to Expect

• Pre-test: avoid heavy exercise 30 min before; avoid lots of caffeine.
• Wear loose-fitting clothing (or you’ll be given gown).
• Inform technician of medications.
• Lie still and relaxed during recording.
• Results often immediate; sometimes electrocardiography reading service.
• Abnormal results may lead to further testing (echo, stress test, cardiology referral).
• Normal EKG doesn’t rule out all heart problems (need other tests for full assessment).
• EKG is screening, not diagnostic for many conditions.

The Bottom Line

An EKG (electrocardiogram, also called ECG) records the electrical activity of the heart through electrodes placed on chest, arms, and legs. Standard 12-lead EKG produces a graph showing rhythm, rate, electrical conduction, and signs of damage or strain. Procedure: lie still on exam table; electrodes placed; 5-10 minutes; painless; results often immediate. EKGs are essential cardiac screening for adults with diabetes. Why important for diabetes: adults with diabetes have 2-4x higher cardiovascular disease risk; silent ischemia is common (autonomic neuropathy can mask chest pain symptoms); baseline EKG provides reference for future changes; detects arrhythmias (atrial fibrillation more common in diabetes), prior heart attack (sometimes silent), left ventricular hypertrophy (from hypertension), conduction problems, QT prolongation (some medications affect), premature beats, bundle branch blocks. ADA recommends EKG at diabetes diagnosis and periodically as clinically indicated. What EKG shows: heart rate (normal 60-100 bpm), rhythm (regular vs irregular), atrial fibrillation (5x stroke risk), ischemia (ST depression, T wave inversion), prior heart attack (Q waves), left ventricular hypertrophy, conduction problems, QT interval, premature beats. When to get EKG: at diabetes diagnosis (baseline), adults over 40 annually or as clinically indicated, hypertension diagnosis, pre-surgical evaluation, cardiovascular symptoms (chest pain, dyspnea, palpitations, syncope), starting QT-prolonging medications, pre-exercise stress testing, suspected arrhythmia, follow-up after cardiovascular event. Diabetes-specific concerns: autonomic neuropathy may mask chest pain (silent ischemia), atrial fibrillation 30-40% more common, hypertension often accompanies diabetes (LVH risk), cardiac autonomic neuropathy affects heart rate variability and orthostatic blood pressure, QT prolongation from some diabetes medications and complications, hypoglycemia can cause arrhythmias. Process: pre-test avoid heavy exercise 30 min before, avoid lots of caffeine, wear loose-fitting clothing, inform technician of medications, lie still during recording. Results often immediate; abnormal results may lead to further testing (echo, stress test, cardiology referral). Normal EKG doesn’t rule out all heart problems — need other tests for full assessment. EKG is screening, not diagnostic for many conditions. Cost: $30-100 without insurance; covered with medical necessity. Most primary care offices have EKG machines. For adults with type 2 diabetes, regular EKG monitoring is essential cardiovascular care — many heart problems are detectable on EKG before symptoms develop. See our broader diabetes heart attack risk guide for context.